French National Cohort of People With Type 1 Diabetes

Launched by FONDATION FRANCOPHONE POUR LA RECHERCHE SUR LE DIABETE · Dec 1, 2020

Keywords

ClinConnect Summary

This clinical trial, called the French National Cohort of People With Type 1 Diabetes, is studying the relationship between blood sugar changes (glycemic variability) and the risk of heart problems in people with type 1 diabetes. Researchers have found that individuals with type 1 diabetes are at a higher risk of heart diseases, even if their blood sugar levels are well controlled. The study aims to gather information from 15,000 participants aged 6 and older to better understand how different factors, including insulin treatments and episodes of low blood sugar (hypoglycemia), may affect heart health over time.

To participate, individuals must have been diagnosed with type 1 diabetes between the ages of 1 and 35 and started insulin treatment within the first year of diagnosis. Participants will be asked to complete online questionnaires, provide various biological samples (like blood and urine), and will be followed for 10 years with check-ins every three years. This study could help identify new ways to improve the health of those living with type 1 diabetes and reduce their risk of heart diseases.

Gender

ALL

Eligibility criteria

• • 1. Inclusion Criteria
• • Adults and children (age \>= 6 years)
• * Type 1 diabetes, defined as:
• • Age at diagnosis of diabetes \> 1 year and \<= 35 years
• • Insulin treatment initiated within the first 12 months following diabetes discovery
• • Affiliation to the French social security scheme (RIPH-2 constraint)
• • Ability to speak and read French
• • Ability to give written informed consent
• • 2. Non-inclusion Criteria Patient under guardianship or protection for vulnerable people